Beacon Equity Research Featured Company: Oramed Pharmaceuticals, Inc. (ORMP.OB)
Oramed Pharmaceuticals, Inc. (ORMP.OB) is a company focused on the commercial development of proprietary oral therapies. Oramed’s main focus is the treatment of diabetes via an oral insulin capsule, which has the potential to help millions of diabetics worldwide. The Company’s oral insulin will better control diabetes by ingesting the capsule at an earlier stage of one’s treatment. Furthermore, based on Oramed’s patented technology, its top scientists are developing other methods of oral delivery for drugs and vaccinations that are currently not available in an oral form. According to the World Health Organization, the global diabetic population exceeds 177 million…